申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04169899A1
公开(公告)日:1979-10-02
Penicillamine compounds of the formula: ##STR1## and of the formula: ##STR2## wherein R.sup.1, R.sup.2, R.sup.3, A and B are as defined hereinafter, and pharmaceutically acceptable acid addition salts thereof are disclosed. II are the products of hydrolysis or alcoholysis of I, and I are in turn the products of dehydration of II or alcohol removal form II. I and II are useful for the treatment of rheumatoid arthritis.
公开了以下式子的青霉胺化合物:
##STR1##
和以下式子的青霉胺化合物:
##STR2##
其中R.sup.1,R.sup.2,R.sup.3,A和B的定义如下,并且它们的药用酸盐也是可接受的。II是I的水解或醇解产物,而I则是II的脱水或醇去除产物。I和II可用于治疗类风湿性关节炎。